Also known as: MBI-226, indolicidin analogue, omiganan pentahydrochloride
Indolicidin-derived synthetic peptide studied for catheter-site and wound antimicrobial activity.

PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Indolicidin-derived synthetic peptide studied for catheter-site and wound antimicrobial activity.
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Omiganan (also known as MBI-226, indolicidin analogue) is studied within the antimicrobial and infection research community. Indolicidin-derived synthetic peptide studied for catheter-site and wound antimicrobial activity.
Last updated October 28, 2026
Research status: active. Omiganan appears across antimicrobial and infection research forums and academic literature. Researchers note this compound falls in the antimicrobial category.
Last updated October 28, 2026
Share your opinion or research experience with Omiganan. Comments are reviewed before appearing.
All products listed on Peptide Stores Online are for in-vitro laboratory and educational research purposes only. Not for human or animal consumption. Not evaluated by the Food and Drug Administration. Not intended to diagnose, treat, cure, or prevent any disease or condition. All sellers and buyers agree to full research-use-only terms at account creation. Peptide Stores Online assumes no liability for misuse of any product listed on this platform.